Register entry
- Registered sites
- 0
- Active NDC listings
- 12
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1212 active NDC listings: 12 plasma derivative. By marketing category: BLA 12.
| Dosage form | NDCs |
|---|---|
| kit | 12 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| csl behring lengnau ag | 12 |
Catalogue
Marketed products
12| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| AFSTYLA Antihemophilic Factor (Recombinant), Single Chain | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | kit | 69911-474BLA |
| AFSTYLA Antihemophilic Factor (Recombinant), Single Chain | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | kit | 69911-475BLA |
| AFSTYLA Antihemophilic Factor (Recombinant), Single Chain | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | kit | 69911-476BLA |
| AFSTYLA Antihemophilic Factor (Recombinant), Single Chain | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | kit | 69911-477BLA |
| AFSTYLA Antihemophilic Factor (Recombinant), Single Chain | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | kit | 69911-478BLA |
| AFSTYLA Antihemophilic Factor (Recombinant), Single Chain | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | kit | 69911-480BLA |
| AFSTYLA Antihemophilic Factor (Recombinant), Single Chain | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | kit | 69911-481BLA |
| IDELVION | Coagulation Factor IX Recombinant Human | kit | 69911-864BLA |
| IDELVION | Coagulation Factor IX Recombinant Human | kit | 69911-865BLA |
| IDELVION | Coagulation Factor IX Recombinant Human | kit | 69911-866BLA |
| IDELVION | Coagulation Factor IX Recombinant Human | kit | 69911-867BLA |
| IDELVION | Coagulation Factor IX Recombinant Human | kit | 69911-869BLA |
Enquiry
Common questions
- Is CSL Behring Lengnau AG FDA approved?
- CSL Behring Lengnau AG holds no registered establishment of its own; 12 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does CSL Behring Lengnau AG make?
- 12 products are listed under CSL Behring Lengnau AG in the openFDA NDC Directory, most often as kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.